Development of Therapeutics for Biodefense and Emerging Infectious Diseases

NIH RePORTER · NIH · N01 · $2,284,288 · view on reporter.nih.gov ↗

Abstract

To support the development of therapeutic products effective against resistant bacterial infections.

Key facts

NIH application ID: 10597509
Project number: 272201600029C-P00021-9999-1
Recipient: VENATORX PHARMACEUTICALS, INC.
Principal Investigator: TIMOTHY HENKEL
Activity code: N01
Funding institute: NIH
Fiscal year: 2022
Award amount: $2,284,288
Award type: —
Project period: 2016-09-23 → 2022-12-31